Baseline characteristics and patient reported outcome data of patients prescribed etanercept: web-based and telephone evaluation

Table 5 Use of methotrexate at baseline

	Rheumatoid arthritis	Ankylosing spondylitis	Psoriatic arthritis	Psoriasis ^a	Other ^b	Total
N [N missing]	190 [1]	43 [0]	44 [0]	35 [0]	19 [12]	331 [13]
Taking methotrexate
No, n (%)	71 (37.4%)	38 (88.4%)	27 (61.4%)	31 (88.6%)	11 (57.9%)	178 (53.8%)
Unsure, n (%)	1 (0.5%)	2 (4.7%)	1 (2.3%)	0 (0.0%)	0 (0.0%)	4 (1.2%)
Yes, n (%)	118 (62.1%)	3 (7.0%)	16 (36.4%)	4 (11.4%)	8 (42.1%)	149 (45.0%)
Route of administration
Tablets, n (%)	97 (82.2%)	3 (100.0%)	11 (68.8%)	3 (75.0%)	6 (75.0%)	120 (80.5%)
Injection, n (%)	21 (17.8%)	0 (0.0%)	5 (31.2%)	1 (25.0%)	2 (25.0%)	29 (19.5%)
Weekly dose
N [N missing]	116 [2]	3 [0]	16 [0]	4 [0]	7 [1]	146 [3]
Mean (SD)	16.6 (6.8)	17.5 (2.5)	15.6 (7.3)	16.2 (9.7)	13.6 (8.9)	16.4 (6.9)
Range	2.5-30.0	15.0-20.0	2.5-25.0	2.5-25.0	2.5-25.0	2.5-30.0
Feedback received
Yes, n (% of not taking)	40 (56.3%)	21 (55.3%)	19 (70.4%)	16 (51.6%)	5 (45.5%)	101 (56.7%)
Ever prescribed ^c
No, n (%)	1 (2.5%)	18 (85.7%)	0 (0.0%)	5 (31.2%)	1 (20.0%)	25 (24.8%)
Unsure, n (%)	1 (2.5%)	1 (4.8%)	0 (0.0%)	1 (6.2%)	0 (0.0%)	3 (3.0%)
Yes, n (%)	38 (95.0%)	2 (9.5%)	19 (100.0%)	10 (62.5%)	4 (80.0%)	73 (72.3%)
Reason stopped ^d
Lack of effect, n (%)	6 (15.8%)	1 (50.0%)	1 (5.3%)	4 (40.0%)	0 (0.0%)	12 (16.4%)
Side effects, n (%)	27 (71.1%)	1 (50.0%)	16 (84.2%)	5 (50.0%)	3 (75.0%)	52 (71.2%)
Doctor stopped, n (%)	5 (13.2%)	0 (0.0%)	2 (10.5%)	1 (10.0%)	1 (25.0%)	9 (12.3%)
Unsure, n (%)	0 (0.0%)	0 (0.0%)	0 (0.0%)	0 (0.0%)	0 (0.0%)	0 (0.0%)

^a Twenty-five patients (71.4%) with psoriasis were also using creams for the condition at baseline, but none of the patients had undergone phototherapy treatment.
^b Includes patients with juvenile idiopathic arthritis (n = 9, 2.6%), patients responding other or not sure of condition (n = 10, 2.9%) and patients with condition missing (n = 12, 3.5%) to the question 'What condition do you have that is being treated with Enbrel?
^c Data for feedback responders (Respondents answering "no" to the question " Are you taking methotrexate" at baseline and providing feedback on any previous use)
^d Data for feedback responders ever prescribed methotrexate (Feedback respondents answering "yes" to the question " Have you ever been prescribed methotrexate")

ISSN: 1471-2288